tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNA Stock Latest News

Avidity Biosciences’ Phase 2 Study on AOC 1001: A Potential Game-Changer for DM1 Treatment
Company AnnouncementsAvidity Biosciences’ Phase 2 Study on AOC 1001: A Potential Game-Changer for DM1 Treatment
7h ago
RNA
PepGen price target raised to $9 from $7 at Wedbush
PremiumThe Fly
PepGen price target raised to $9 from $7 at Wedbush
13d ago
RNA
PEPG
Netflix upgraded, Five Below initiated: Wall Street’s top analyst calls
PremiumThe Fly
Netflix upgraded, Five Below initiated: Wall Street’s top analyst calls
21d ago
Z
KR
Avidity Biosciences initiated with a Buy at Roth Capital
PremiumThe Fly
Avidity Biosciences initiated with a Buy at Roth Capital
22d ago
RNA
Avidity Biosciences falls -8.2%
PremiumThe Fly
Avidity Biosciences falls -8.2%
23d ago
RNA
Avidity Biosciences falls -5.4%
PremiumThe FlyAvidity Biosciences falls -5.4%
23d ago
RNA
3 Best Stocks to Buy Now, 9/15/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/15/2025, According to Top Analysts
24d ago
MH
RNA
Avidity Biosciences price target raised to $65 from $56 at BofA
Premium
The Fly
Avidity Biosciences price target raised to $65 from $56 at BofA
24d ago
RNA
Avidity Biosciences Announces Major Stock Offering
PremiumCompany Announcements
Avidity Biosciences Announces Major Stock Offering
26d ago
8K
RNA
Avidity Biosciences price target raised to $87 from $68 at H.C. Wainwright
PremiumThe Fly
Avidity Biosciences price target raised to $87 from $68 at H.C. Wainwright
27d ago
RNA
Avidity Biosciences 15M share Secondary priced at $40.00
PremiumThe Fly
Avidity Biosciences 15M share Secondary priced at $40.00
27d ago
RNA
Kroger reports mixed Q2, U.S. CPI rises 0.4% in August: Morning Buzz
PremiumThe Fly
Kroger reports mixed Q2, U.S. CPI rises 0.4% in August: Morning Buzz
27d ago
KR
CNC
Avidity Biosciences falls -18.2%
PremiumThe FlyAvidity Biosciences falls -18.2%
27d ago
RNA
Avidity Biosciences falls -19.5%
Premium
The Fly
Avidity Biosciences falls -19.5%
27d ago
RNA
Avidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion
Premium
Ratings
Avidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion
27d ago
RNA
Avidity Biosciences price target raised to $56 from $54 at BofA
PremiumThe Fly
Avidity Biosciences price target raised to $56 from $54 at BofA
28d ago
RNA
Avidity Biosciences
PremiumThe Fly
Avidity Biosciences
28d ago
RNA
Avidity Biosciences’ Del-Zota Shows Promising Data in DMD, Justifying Buy Rating and $56 Price Target
PremiumRatings
Avidity Biosciences’ Del-Zota Shows Promising Data in DMD, Justifying Buy Rating and $56 Price Target
28d ago
RNA
Closing Bell Movers: Opendoor up 36% after management reshuffle
PremiumThe Fly
Closing Bell Movers: Opendoor up 36% after management reshuffle
28d ago
OXM
Avidity Biosciences announces $500M common stock offering
PremiumThe FlyAvidity Biosciences announces $500M common stock offering
28d ago
RNA
Cantor finds Avidity data highly supportive of del-zota best-in-class potential
Premium
The Fly
Cantor finds Avidity data highly supportive of del-zota best-in-class potential
28d ago
RNA
Avidity Biosciences: Promising Phase 1/2 Trial Results and FDA Agreement Boost Buy Rating
Premium
Ratings
Avidity Biosciences: Promising Phase 1/2 Trial Results and FDA Agreement Boost Buy Rating
28d ago
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >